With telemedicine still a burgeoning market, we take a look at some of the top competitors to Teladoc within the industry.
May 26, 2022
After a recent IPO and an impressive inaugural quarterly report as a public company, we delve into three of Doximity’s competitors.
Aug 24, 2021
We take care of the first one so you can focus on the other two!
After the IPO madness we saw in 2020, what lessons can we utilize in 2021 to build a healthy investment strategy for this year’s IPO market
Jan 9, 2021
The race to dominate the telehealth space is heating up, so in this rapidly expanding market, which is a better investment: the first mover or the hot IPO?
Oct 3, 2020
The company should reap up to $560 million in gross proceeds from the issue.
Sep 9, 2020
One new telemedicine service has been given a boost from a massive stock-market player.
Aug 28, 2020